Preapproval Information Exchange: Perspectives of U.S. Population Health Decision Makers on Preferences for Early Engagement with Investigational Therapies by Brixner, Diana, Woodward, Tatia C., Seifter, Nik, Biskupiak, Joseph, Marciniak, Martin, Neumann, Peter, Oderda, Gary

Get full text

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA tr... by Barretina-Ginesta, Maria-Pilar, Monk, Bradley J., Han, Sileny, Pothuri, Bhavana, Auranen, Annika, Chase, Dana M., Lorusso, Domenica, Anderson, Charles, Abadie-Lacourtoisie, Sophie, Cloven, Noelle, Braicu, Elena I., Amit, Amnon, Redondo, Andrés, Shah, Ruchit, Kebede, Nehemiah, Hawkes, Carol, Gupta, Divya, Woodward, Tatia, O’Malley, David M., González-Martín, Antonio

Get full text

Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder by Woodward, Tatia Chay, Tafesse, Eskinder, Quon, Peter, Lazarus, Arthur

Get full text

Real-world clinical outcomes with poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitors as second-line maintenance therapy in patients with recurrent ovarian cancer in th... by Matulonis, Ursula, Mirza, Mansoor, Malinowska, Izabela, Perhanidis, Jessica, Woodward, Tatia, Kalilani, Linda

Get full text

Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial by Chase, Dana M., Marín, Margarita Romeo, Backes, Floor, Han, Sileny, Graybill, Whitney, Mirza, Mansoor Raza, Pothuri, Bhavana, Mangili, Giorgia, O'Malley, David M., Berton, Dominique, Willmott, Lyndsay, Baumann, Klaus, Coleman, Robert L., Safra, Tamar, Heinzelmann-Schwarz, Viola, Lorusso, Domenica, Karl, Florian M., Woodward, Tatia, Monk, Bradley J., Gonzalez-Martin, Antonio

Get full text